The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) View the PDF document
Table of Contents
View the documentAuthors
View the documentCountry Research Team Leaders
View the documentLaboratory Support
View the documentAcknowledgements
View the documentAcronyms
View the documentExecutive summary
View the document1. Background
Open this folder and view contents2. Methodology
View the document3. Results
Open this folder and view contents4. Discussion
Open this folder and view contents5. Conclusions and recommendations
View the documentReferences
Open this folder and view contentsTables
Close this folderAnnexes
View the documentANNEX: 1A
View the documentANNEX: 1B
View the documentANNEX: 1C
View the documentANNEX: 2A
View the documentANNEX: 2B
View the documentANNEX: 2C
View the documentANNEX: 3A
View the documentANNEX: 3B
View the documentANNEX: 3C
View the documentANNEX: 4A
View the documentANNEX: 4B
View the documentANNEX: 4C
View the documentANNEX: 5A
View the documentANNEX: 5B
View the documentANNEX: 5C
View the documentANNEX: 6A
View the documentANNEX: 6B
View the documentANNEX: 6C
View the documentANNEX: 7A
View the documentANNEX: 7B
View the documentANNEX: 7C
View the documentOther documents in the EDM Research Series
View the documentEDM Research Series No. 30
 

ANNEX: 5A

Country: Mozambique
Product: Chloroquine syrup

       

CENQAM LAB RESULTS

       

Active ingredient content

CENQAM
REF NO

Sample
number

CP

Manufacturer

1st
value

2nd
value

3rd
value

Mean
value

Low
fail
<90%

High
fail
>110%

Pass
90 - 110%

20010405

MO/CQS/PH15

P

Simrone
Pharm, India

102.59

102.48

-

102.53

-

-

102.53

20010406

MO/CQS/PH19

P

Simrone
Pharm, India

104.64

107.07

105.24

105.65

-

-

105.65

20010412

MO/CQS/PH001

P

Simrone
Pharm, India

108.74

112.66

106.22

109.21

-

-

109.21

20010409

MO/CQS/PH/01

P

Simrone
Pharm, India

108.38

112.02

106.42

108.94

-

-

108.94

20010413

MO/CQS/PH03

P

Simrone
Pharm, India

108.77

104.29

114.04

109.03

-

-

109.03

20010459

MO/CQS/TH27

TH

Pharco Pharm, Alexandria

98.24

99.86

-

99.05

-

-

99.05

20010458

MO/CQS/TH001

TH

Pharco Pharm, Alexandria

99.33

100.69

-

100.01

-

-

100.01

20010424

MO/CQS/PH04

P

Pharco Pharm, Alexandria

96.04

101.04

101.42

99.50

-

-

99.50

200104103

MO/CQS/CS02

CMS

Pharm Indus Lab, Sudan

119.69

118.61

119.29

119.20

-

119.20

-

200104105

MO/CQS/CS03

CMS

Pharma Danica

107.73

109.60

-

108.67

-

-

108.67

200104108

MO/CQS/PH02

P

Belta Pharma, Italy

121.05

121.87

118.28

120.40

-

120.40

-

200104156

MO/CQS/CS01

CMS

Ulticare-Lyka, Nigeria

117.8

-

-

117.8

-

117.8

-

REF NO: Reference number

CP: Collection point

 

CMS: Central medical stores

P: Pharmacy

TH: Teaching hospital

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018